Javascript must be enabled to continue!
Apoptotic response of eosinophils in chronic eosinophilic pneumonia
View through CrossRef
To clarify the pathogenesis of chronic eosinophilic pneumonia (CEP), the apoptosis of eosinophils from bronchoalveolar lavage (BAL-Eos) was compared with that of eosinophils from peripheral blood (PB-Eos) in six cases of CEP.The survival rate of eosinophils and the percentage of apoptotic cells of both types of eosinophils were examined, and the effects of interleukin 5 (IL-5) were evaluated. The role of Fas expression in apoptosis of these eosinophils was also studied.The survival rate of BAL-Eos on the third day of culture was significantly higher than that of PB-Eos (p<0.01). This was associated with a lower proportion of apoptotic cells in BAL-Eos than in PB-Eos; the percentages of apoptotic cells in PB-Eos and BAL-Eos after 24 h of incubation were 21.7±3.4% and 10.6±1.7% respectively. IL-5 suppressed apoptosis and increased the survival rate of both PB-Eos and BAL-Eos. It was found that the apoptotic character of BAL-Eos differed from that of PB-Eos in at least three ways. Firstly, the positive rate of Fas expression on PB-Eos was increased after 24 h of incubation, whereas that on BAL-Eos did not change. Secondly, the expression of Fas on PB-Eos was suppressed by IL-5 (18.5±4.2%–8.3±3.2%, p<0.05), whereas IL-5 failed to suppress Fas expression on BAL-Eos (3.3±1.6%–3.6±1.0%). Lastly, binding of antibody to Fas antigen induced apoptosis of PB-Eos, but not of BAL-Eos.These data suggested that Fas seemed to be involved in the apoptosis of PB-Eos, whereas BAL-Eos were Fas-resistant in chronic eosinophilic pneumonia. In conclusion, apoptosis of eosinophils might be suppressed by proinflammatory cytokines such as IL-5 leading to their accumulation in the lung. Chronic stimulation of eosinophils in the alveolar space with IL-5 may play a crucial role chronic eosinophilic disorders.
European Respiratory Society (ERS)
Title: Apoptotic response of eosinophils in chronic eosinophilic pneumonia
Description:
To clarify the pathogenesis of chronic eosinophilic pneumonia (CEP), the apoptosis of eosinophils from bronchoalveolar lavage (BAL-Eos) was compared with that of eosinophils from peripheral blood (PB-Eos) in six cases of CEP.
The survival rate of eosinophils and the percentage of apoptotic cells of both types of eosinophils were examined, and the effects of interleukin 5 (IL-5) were evaluated.
The role of Fas expression in apoptosis of these eosinophils was also studied.
The survival rate of BAL-Eos on the third day of culture was significantly higher than that of PB-Eos (p<0.
01).
This was associated with a lower proportion of apoptotic cells in BAL-Eos than in PB-Eos; the percentages of apoptotic cells in PB-Eos and BAL-Eos after 24 h of incubation were 21.
7±3.
4% and 10.
6±1.
7% respectively.
IL-5 suppressed apoptosis and increased the survival rate of both PB-Eos and BAL-Eos.
It was found that the apoptotic character of BAL-Eos differed from that of PB-Eos in at least three ways.
Firstly, the positive rate of Fas expression on PB-Eos was increased after 24 h of incubation, whereas that on BAL-Eos did not change.
Secondly, the expression of Fas on PB-Eos was suppressed by IL-5 (18.
5±4.
2%–8.
3±3.
2%, p<0.
05), whereas IL-5 failed to suppress Fas expression on BAL-Eos (3.
3±1.
6%–3.
6±1.
0%).
Lastly, binding of antibody to Fas antigen induced apoptosis of PB-Eos, but not of BAL-Eos.
These data suggested that Fas seemed to be involved in the apoptosis of PB-Eos, whereas BAL-Eos were Fas-resistant in chronic eosinophilic pneumonia.
In conclusion, apoptosis of eosinophils might be suppressed by proinflammatory cytokines such as IL-5 leading to their accumulation in the lung.
Chronic stimulation of eosinophils in the alveolar space with IL-5 may play a crucial role chronic eosinophilic disorders.
Related Results
Biomarker profiles and immune cell populations in distinct asthma endotypes
Biomarker profiles and immune cell populations in distinct asthma endotypes
<p dir="ltr">Asthma affects 260 million individuals globally and imposes a substantial health burden. Its hallmarks include chronic airway inflammation, airway hyperresponsiv...
Biomarker profiles and immune cell populations in distinct asthma endotypes
Biomarker profiles and immune cell populations in distinct asthma endotypes
<p dir="ltr">Asthma affects 260 million individuals globally and imposes a substantial health burden. Its hallmarks include chronic airway inflammation, airway hyperresponsiv...
The Impact of IL28B Gene Polymorphisms on Drug Responses
The Impact of IL28B Gene Polymorphisms on Drug Responses
To achieve high therapeutic efficacy in the patient, information on pharmacokinetics, pharmacodynamics, and pharmacogenetics is required. With the development of science and techno...
Eosinophils and Bacteria, the Beginning of a Story
Eosinophils and Bacteria, the Beginning of a Story
Eosinophils are granulocytes primarily associated with TH2 responses to parasites or immune hyper-reactive states, such as asthma, allergies, or eosinophilic esophagitis. However, ...
Anti-IL5 mepolizumab minimally influences residual blood eosinophils in severe asthma
Anti-IL5 mepolizumab minimally influences residual blood eosinophils in severe asthma
Neutralising antibodies against the cytokine interleukin (IL)5 have become widely used for the control of severe eosinophilic asthma. Remarkably, patients receiving neutralising an...
Understanding motivations and patterns of care-seeking and adherence to medical treatments for paediatric pneumonia in Nigeria
Understanding motivations and patterns of care-seeking and adherence to medical treatments for paediatric pneumonia in Nigeria
<p dir="ltr">Background: Nigeria has the highest number of childhood pneumonia deaths worldwide, and it is not on track to meet the sustainable development goal 3.2. Despite ...
Understanding motivations and patterns of care-seeking and adherence to medical treatments for paediatric pneumonia in Nigeria
Understanding motivations and patterns of care-seeking and adherence to medical treatments for paediatric pneumonia in Nigeria
<p dir="ltr">Background: Nigeria has the highest number of childhood pneumonia deaths worldwide, and it is not on track to meet the sustainable development goal 3.2. Despite ...
Fatal outcomes analysis in pneumonia patients in St. Petersburg (2020–2024)
Fatal outcomes analysis in pneumonia patients in St. Petersburg (2020–2024)
Background: pneumonia, together with other lower respiratory tract infections, remains one of the leading causes of mortality worldwide.
Aim: to analyze the fatal outcomes of pneum...

